Keyphrases
Liver Transplant Recipients
100%
Dosing Schedule
100%
Hepatitis B Immunoglobulin
100%
Fixed Dosing
100%
Hepatitis B Surface Antigen (HBsAg)
90%
Reinfection
20%
Pretransplant
20%
Immunoprophylaxis
20%
Hepatitis B Virus DNA
20%
Inter-patient Variability
20%
Medical Center
10%
Liver
10%
Long-term Efficacy
10%
High Dose
10%
Lymphocytes
10%
Fixed-dose Combination
10%
Hepatitis B e Antigen (HBeAg)
10%
Treatment Regimen
10%
Viral Replication
10%
Recurrence Rate
10%
Antibody to Hepatitis B Core Antigen
10%
Hepatitis B Virus
10%
Patient-specific Therapy
10%
Polymerase Chain Reaction Amplification
10%
Hybridization Assay
10%
Antigenemia
10%
Residual Virus
10%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Hepatitis B
100%
HBsAg
70%
Hepatitis B Antigen
70%
Hepatitis B Virus
30%
Titer
30%
Hepatitis B Surface Antibody
30%
DNA Virus
20%
Viral Replication
10%
Drug Megadose
10%
Hepatitis B(e) Antigen
10%
Immunology
10%
Lymphocyte
10%
Polymerase Chain Reaction
10%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Hepatitis B
100%
Hepatitis B Antigen
70%
Hepatitis B Virus
30%
Hepatitis B Antibody
30%
Reinfection
20%
Virus DNA
20%
Recurrent Disease
10%
Hepatitis B(e) Antigen
10%
Recurrence Risk
10%